✦ LIBER ✦

Poster #T8 EFFICACY AND SAFETY OF OLANZAPINE LONG-ACTING INJECTION IN PATIENTS WITH SCHIZOPHRENIA: A POST-HOC ANALYSIS OF A 6-YEAR MULTINATIONAL SINGLE-ARM OPEN-LABEL STUDY

✍ Scribed by Anand, Ernie; Berggren, Lovisa; Toth, Agoston; McDonnell, David

Book ID: 122222960
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 92 KB
Volume: 153
Category: Article
ISSN: 0920-9964
DOI: 10.1016/S0920-9964(14)70825-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single- and Multiple-Dose Pharmacokineti

Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia

✍ Mitchell, Malcolm; Kothare, Prajakti; Bergstrom, Richard; Zhao, Fangyi; Jen, Kai 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Safety and efficacy of long-acting injec

Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients

✍ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or